TFTito Fiore

Tito Fiore

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tito Fiore has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Exudative Retinal Detachment in Inflammatory Ocular Diseases: Epidemiology, Clinical and Imaging Characteristics in Two Referral Hospitals in Italy

    by Barbara Iaccheri, Elena Bolletta, Alessio Cerquaglia, Francesco Della Lena, Nicola De Santi, Chiara Solito, Daniela Fruttini, Carlo Cagini, Luca Cimino, Tito Fiore

    The aim of the study was to analyze the epidemiological, clinical and imaging characteristics of patients with inflammatory exudative retinal detachment (ERD). This multicenter, retrospective, observational study enrolled patients with a diagnosis of an inflammatory ocular disease associated with ERD. In all patients a complete ophthalmological evaluation was performed, with best-corrected visual acuity (BCVA), automated refraction, slit lamp biomicroscopy, intraocular pressure (IOP), fundus examination, optic coherence tomography (OCT) scan, color fundus photography, fluorescein angiography (FA) and indocyanine green angiography (ICGA). ERD was located (posterior pole, peripheral retina or both) with imaging, and the presence or absence of subfoveal neuroepithelial detachment, retinal pigment epithelium (RPE) detachment, epiretinal membrane (ERM), and macular edema (ME) were documented. 130 patients were enrolled, with a mean age of 52.14 ± 20.69 years. The most representative diagnosis was Vogt-Koyanagi-Harada (VKH) disease (23.85%), followed by Sarcoidosis (16.15%), Tuberculosis (13.08%) and Posterior Scleritis (PS) (9.23%). The principal location of ERD in the 165 enrolled eyes was in the posterior pole. In VKH, ERD was located at the posterior pole in 45 eyes, with 85.71% of subfoveal neuroepithelial detachment and choroidal granulomas in 87.76% of eyes. In PS a posterior pole location of ERD was found in 66.67% of eyes, with 83.33% of subfoveal neuroepithelial detachment and no choroidal granulomas. ERD is most frequently associated with VKH disease and the predominant localization is at the posterior pole, which occurs in the setting of posterior uveitis, panuveitis, and/or scleritis.

  • Optic disc neovascularization in inflammatory eye diseases: A review of pathogenesis, clinical features, and management

    by Giuseppe Mirabella, Barbara Iaccheri, Federica Mirabella, Nicola De Santi, Tito Fiore, Carlo Cagini, Alessio Cerquaglia

    To review the pathogenesis, clinical presentation, and management of inflammatory optic disc neovascularization (ODN). ODN is a rare but vision-threatening complication of uveitis. Traditionally associated with retinal ischemia, recent evidence shows that ODN can arise even in well-perfused eyes, driven by chronic inflammation. A total of 102 reported cases of ODN in uveitic eyes without angiographic evidence of retinal ischemia were reviewed, analysing the underlying conditions, anatomical patterns, complications, and therapeutic responses. The optic disc was the exclusive site of neovascularization, often linked to prolonged inflammation. Diagnosis relied on angiographic and OCT-A imaging. Anti-inflammatory treatment was the cornerstone, with corticosteroids and immunosuppressants showing good efficacy. Anti-VEGF agents offered adjunctive benefits, especially in acute or haemorrhagic cases. An illustrative case of acute anterior uveitis with isolated ODN is presented; the neovascularization resolved after combined steroid and anti-VEGF therapy. ODN may emerge as a complication of uveitis even in the absence of ischemia. Recognizing its inflammatory nature is essential for appropriate treatment and to prevent vision-threatening sequelae.

  • Epidemiology of Uveitis and Extra-Uveal Inflammation in a Referral Center in Central Italy

    by Barbara Iaccheri, Nicola De Santi, Alessio Cerquaglia, Mariarosaria Giugliano, Francesco Della Lena, Giuseppe Mirabella, Chiara Solito, Daniela Fruttini, Carlo Cagini, Tito Fiore

    The epidemiology of uveitis remains highly variable, influenced by geographic location, genetic predisposition, environmental conditions, and socioeconomic context leading to significant differences in the distribution of clinical forms. The aim of this report was to analyse the epidemiological profile of uveitis at the tertiary referral center in Italy, providing a comprehensive overview of prevalence, clinical classifications, and etiological diagnoses. A retrospective study had been performed in a reference uveitis center in Italy, collecting data from February 2019 to December 2024. Demographic data, aetiology diagnosis and clinical characteristic were reported. Study enrolled 752 patients with ocular inflammation, 623 of whom had uveitis. Female represented the 58.51%, while the majority of patients were Caucasian (92.15%). Mean age was 51 years with middle-aged group represented the 68.75%. Noninfectious, including idiopathic forms, was the main aetiology (77.13%), followed by infectious (22.87%). Anterior uveitis (AU) was the 56.34%, posterior uveitis the 26.48%, panuveitis 11.57% and intermediate (IU) 5.61%. A statistically significant association was found between the aetiology and the localization (p < 0.0001). Herpetic infectious, HLA-B27-related, Fuchs, Toxoplasma and Sarcoidosis represented the main diagnosis. The study documented the epidemiology trend of uveitis, comparing with other European studies. Females and middle-aged group were the most frequent involvement groups. Noninfectious disease represented the primary etiologic cause. The AU was the main localization of inflammation. These results contribute to a better understanding of the distribution of uveitis in the region and help improve diagnostic and therapeutic processes.


  • Open Access

    When the Eye Reveals Disseminated Tuberculosis: A Pediatric Case of Endophthalmitis With Severe CNS Involvement

    by Nicola De Santi, Laura Curci, Eduardo Bianchi, Barbara Iaccheri, Carlo Pallotto, Daniele Rosignoli, Tito Fiore, Giuseppe Vittorio Luigi De Socio, Carlo Cagini

    Purpose: This study aims to report a case of tuberculosis involving central nervous system (CNS) discovered thanks to tubercular endophathlmitis. Methods: This is a case report. Observation: A 14‐year‐old male presented with acute visual loss, ocular pain, and redness of the right eye following a recent stay in India. The clinical history was notable for prolonged fever, night sweats, and headache. Ophthalmological examination revealed severe intraocular inflammation consistent with panuveitis and endophthalmitis. Neuroimaging demonstrated a large ring‐enhancing lesion in the right hemisphere with significant mass effect. Initial microbiological investigations, including vitreous sampling, were negative. A positive interferon‐gamma release assay and radiological findings raised suspicion for disseminated tuberculosis, and Mycobacterium tuberculosis DNA was subsequently detected in vitreous samples after repeating a second vitrectomy. Antitubercular therapy was started and definitive diagnosis was made with biopsy of the brain lesion, which demonstrated positive cultures for drug‐sensitive M. tuberculosis . The clinical course was complicated by retinal detachment, paradoxical enlargement of the cerebral tuberculoma, and postoperative neurological deficits requiring surgical intervention and rehabilitation. Conclusion: This case highlights the diagnostic complexity of ocular and CNS tuberculosis and emphasizes the need for a high index of suspicion, repeated targeted sampling, and multidisciplinary management to achieve timely diagnosis and appropriate treatment.

  • Functional and Structural Impact of Switching to Bevacizumab in neovascular-AMD Patients Treated with Aflibercept or Ranibizumab

    by Alessio Muzi, Giulia Gregori, Lorenzo Mangoni, Veronica Mogetta, Jay Chhablani, Daniela Fruttini, Tito Fiore, Clara Rizzo, Cesare Mariotti, Marco Lupidi

    Purpose: To evaluate the functional and structural outcomes in patients with neovascular age-related macular degeneration (nAMD) switched from ranibizumab or aflibercept to bevacizumab. Methods: This retrospective study included 197 eyes of 192 patients (mean age 83 ± 6 years; 38% male). Patients previously treated with ranibizumab (n = 79) or aflibercept (n = 118) were transitioned to bevacizumab. Best-corrected visual acuity (BCVA) was recorded with ETDRS charts and converted to logMAR. Spectralis SD-OCT was used to evaluate intraretinal and subretinal fluid, presence of retinal pigment epithelium detachment (PED), PED height and central retinal thickness (CRT) at baseline and after 6 months. Results: Mean BCVA decreased from 0.4 ± 0.3 to 0.5 ± 0.4 logMAR (p = 0.048). The proportion of eyes with intraretinal or subretinal fluid rose from 27% to 69% (p = 0.017). Subgroup analysis indicated greater functional and structural worsening in younger patients and in those switched from aflibercept. Mean PED height showed a non-significant increase from 163 ± 94 to 166 ± 95 µm (p = 0.091), mean PED height showed a non-significant increase from 163 ± 94 to 166 ± 95 µm (p = 0.091). In contrast, mean CRT increased substantially from 294 ± 30 µm at baseline to 310 ± 26 at 6 months (p (p < 1 × 10 −7 ). Conclusions: Switching from ranibizumab or aflibercept to bevacizumab may lead to reduced visual function and an increase in structural-OCT markers of disease activity, including greater intraretinal/subretinal fluid, CRT and worsening PED features, particularly in younger individuals and in eyes previously treated with aflibercept.


  • Safety of intravitreal injections with the mobile laminar airflow device Operio after more than 10.000 injections

    by Tito Fiore, Nicola De Santi, Eduardo Bianchi, Alessio Cerquaglia, Marco Lupidi, Gianluigi Tosi, Carlo Cagini

    Purpose To evaluate the occurrence of complications following intravitreal injections (IVIs) performed in an outpatient clean room (OCR) equipped with the mobile laminar airflow device (LAF) Operio. Methods This retrospective study analyzed the data of 10,016 IVIs performed in an OCR from April 2023 to November 2024. All information of each patient was registered, such as diagnosis, drug injected and any occurring complication or adverse events such as endophthalmitis, intraocular inflammation, rhegmatogenous retinal detachment (RRD), vitreous hemorrhages and elevated intraocular pressure. Results From April 2023 to November 2024, 10,016 IVIs were performed in 1700 eyes of 1460 patients with the average age of 76.10 ± 12.37 years. The most representative diagnosis were Age-related Macular Degeneration (AMD) (47.60%), Retinal Vein Occlusion (RVO) (18.90%) and Diabetic Macular Edema (DME) (8.42%). Ten (4.24%) cases of ocular hypertensions were reported after dexamethasone implant whereas no cases of endophthalmitis or RRD were registered. Conclusions The OCR equipped with Operio was easy to set up, safe regarding all IVI-related complications, first and foremost endophthalmitis, helpful in improving the management of IVIS, and allowed us to decongest the operating room for more complex surgeries.


  • Optic disc pit maculopathy: Covering or filling technique with human amniotic membrane patch to treat the optic disc pit maculopathy?

    by Tito Fiore, Davide Tucci, Nicola De Santi, Marco Lupidi, Carlo Cagini, Cesare Mariotti

    Purpose: To describe two patients affected by optic disk pit-maculopathy ODP-M surgically treated with pars-plana vitrectomy (PPV) and the apposition of a human Amniotic Membrane (hAM) patch. Methods: Patients underwent a PPV with the apposition of a hAM patch to cover the ODP. In case 1, a 2nd surgery was necessary to push the hAM patch inside the pit, whereas in case 2 the patch was pulled inside the pit following the pressure gradient when infusion was turned on. Results: After surgery the hAM patch filled the ODP and in both cases, during follow-up, there was a progressive reduction of macular OCT changes and a concomitant BCVA improvement. Conclusion: Our experience seems to support the idea that the dynamic fluctuation of pressure between intra-ocular and intra-cranial spaces can direct the movement of fluid through the anomalous communication created by the ODP. In this perspective, our cases seem to support the idea that the primary goal of any surgery should be to create a permanent barrier to fluid migration through the ODP to the intra-ocular space, and that hAM can be successfully used to fill the OPD and to create that permanent barrier to achieve the resolution of ODP-M.


  • Evaluation of warm compresses and topical cyclosporine treatment in meibomian gland dysfunction by confocal scanning laser microscopy

    by Barbara Iaccheri, Giovanni Torroni, Alessio Cerquaglia, Marco Messina, Davide Tucci, Daniela Fruttini, Carlo Cagini, Tito Fiore

    Purpose: The aim of our study is to confirm the utility of warm compresses (WC) and artificial tears (AT) in meibomian gland dysfunction (MGD) management and to understand if its association with topical cyclosporine A (CsA) improves outcomes. Methods: Patients with diagnosis of MGD-related dry eye were evaluated. In this prospective, randomized, double-masked study, patients were randomized in two treatments: AT plus WC (group A), and AT plus WC plus CsA 0.05% ophthalmic emulsion (group B). At baseline and at 1, 3, and 6 months, Ocular Surface Disease Index (OSDI) questionnaire was completed, and tear evaluation (BUT, Schirmer and osmolarity test), ocular surface evaluation (fluorescein and lissamine green staining), clinical (Shimazaki grading) and in vivo confocal microscopy (IVCM) evaluation of rete ridges (RRs) were performed. Results: A total of 40 eyes, 20 in each group, completed the study. Analysis of OSDI, tear test, ocular surface evaluation and clinical grading of MG showed significant improvement at 6 months, whereas no difference was found between the two groups at 6 months. The analysis of IVCM showed significant improvement in both groups, but significantly better results in group B were found compared to group A at 6 months. Conclusion: WC performed 3 times daily during the 1st month and once daily afterwards, in addition to AT, were useful to manage the obstruction of MG and related signs and symptoms. Additional effects of CsA were visible in IVCM only at 6 months. IVCM is an effective tool to monitor treatments in MGD.


  • Primary small gauge pars plana vitrectomy and silicone oil endotamponade for endophthalmitis after cataract surgery: Clinical and OCT findings

    by Tito Fiore, Marco Lupidi, Alessio Cerquaglia, Fabrizio Giansanti, Michele Reibaldi, Barbara Iaccheri, Davide Tucci, Marco Messina, Carlo Cagini

    Background: Retrospective analysis of morphological and functional outcomes after pars-plana vitrectomy and Silicone-Oil (SO) endotamponade in acute postoperative endophthalmitis (APOE). Methods: Minimum follow-up was 6 months. Every included patient received best-corrected visual acuity (BCVA) assessment, pre-operatively and at last follow-up. Spectralis OCT was used to investigate disorganization of inner (DRIL) and outer (DROL) retinal layers at 1, 3, 6 months and at last follow-up. OCT-A was performed to assess foveal avascular zone (FAZ) and vascular perfusion density (VPD) at 6 months and at last follow-up. Results: Seventeen eyes were recruited. Postoperative findings: BCVA ≥ 20/40 (in 14 eyes); epiretinal membranes (13); hyperreflective epiretinal material soon after surgery in (6) SO-filled eyes; inner retinal layers atrophy (5); macular edema (2); DROL (4) with persistent EZ disruption at final visit (2); no significant difference between study and fellow eyes in central macular thickness, FAZ and VPD; VPD decreased in all cases with prominent disorganization of retinal architecture. Conclusion: OCT changes after APOE can be persistent or completely/partially self-resolving and seems related to the outward progression path of the infection/inflammation from the vitreous cavity to the inner and outer retina, rather than to the surgery.


  • Choroidal vasculature analysis in MEK inhibitor-associated retinopathy

    by Alessio Cerquaglia, Marco Lupidi, Jay Chhablani, Ramkailash Gujar, Barbara Iaccheri, Tito Fiore, Daniela Fruttini, Antonello Ramundo, Kiran Kumar Vupparaboina, Luca Castellani, et al.

    Purpose: To evaluate choroidal vascularity index (CVI) in patients developing mitogen-activated protein kinase kinase (MEK) inhibitor-associated retinopathy (MEKAR). Methods: In this prospective observational study, extensive ophthalmic examination was performed, including enhanced-depth-imaging-optical coherence tomography (EDI-OCT). EDI-OCT scans of patients receiving Cobimetinib, taken at baseline and at MEKAR manifestation, were considered for choroid analysis. Choroidal thickness (CT) was measured on high-resolution b-scans passing through the fovea at three different locations. Same scans were therefore imported for binarization into a previously reported software and CVI was calculated as the ratio of luminal area (LA) to total choroid area (TCA). Results: When compared to baseline, eyes with MEKAR (14 eyes) did not show significative CT variation in subfoveal region (p = 0,57), 750-µm-nasal to the fovea (p = 0,08) and 750-µm-temporal to the fovea (p = 0,07). Similarly, there were no statistically significant differences for TCA (p = 0.54), LA (p = 0.85), stromal area (SA) (p = 0.13), LA/SA (p = 0.34) and CVI (p = 0.47). Best-corrected visual acuity was significantly reduced at fluid accumulation when compared to baseline values (p = 0.03), with complete recovery after fluid resolution (p = 0.73). Conclusion: Multiple parameters reflecting the status of the choroid seemed not influenced by Cobimetinib administration. Retinal pigment epithelium toxic disfunction likely represents the crucial step in MEKAR pathogenesis.